Ask a question
Presentation
15:00 CET / 09:00am ET
Program:
15:00 Welcome address, agenda & company overview – Martin Jönsson, CEO, AlzeCure
15:10 Alzheimer’s and amyloid hypothesis – Henrik Zetterberg1, MD, PhD, Gothenburg Univ. & University College London
15:50 Alzstatin: a small molecule disease modifying and preventive therapy against Alzheimer’s – Johan Sandin, PhD, CSO, AlzeCure
16:05 Q&A
16:25 Concluding remarks – Martin Jönsson, CEO, AlzeCure
![](https://www.finwire.tv/wp-content/uploads/2022/01/Martin.jpg)
Martin Jönsson / VD AlzeCure
![](https://www.finwire.tv/wp-content/uploads/2024/02/Alzecure.jpeg)
Henrik Zetterberg1, MD, PhD, Gothenburg Univ. & University College London
![](https://www.finwire.tv/wp-content/uploads/2023/05/alzecurepharma-johan-sandin-people-bw.jpg)
Johan Sandin, PhD, CSO, AlzeCure